Abstract The American Migraine Foundation estimates that over 39 million Americans and over 1 billion people worldwide suffer from some…
Abstract Background/Objectives: Chronic pain remains a pervasive and challenging public health issue, often resistant to conventional treatments such as opioids,…
Abstract Background: The therapeutic use of cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) to treat migraine has been understudied. Using three mouse…
Abstract Background and Objectives: Primary headaches are highly prevalent among medical students, negatively impacting their health and academic performance. Excessive…
Abstract Background: The COVID-19 pandemic has become a global health issue and has significantly impacted university education. As a result,…
Abstract The endocannabinoid system (ECS) influences many biological functions, and hence, its pharmacological modulation may be useful for several disorders,…
Abstract Cannabis has been long used since ancient times for both medical and recreational use. Past research has shown that…
Abstract Background: Medicinal cannabis registries typically report pain as the most common reason for use. It would be clinically useful…
Abstract Headache disorders are common, debilitating, and, in many cases, inadequately managed by existing treatments. Although clinical trials of cannabis…
Abstract Objective(s):The objective of this study was to evaluate the effect of cannabinoid on cortical spreading depression (CSD) in rat…